|9.53||+0.41 / +4.50%|
As of 3:59pm ET
|9.53||+0.0019 / +0.02%|
The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +162.33% increase from the last price of 9.53.
The current consensus among 1 polled investment analysts is to Buy stock in InVivo Therapeutics Holdings Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.